Avalon Globocare Corp (ALBT) USD0.0001
Sell:$4.60Buy:$4.80
$0.08
(1.64%)
- This stock can be held in a
Stocks and Shares ISA$0.08
(1.64%)$0.08
(1.64%)Company Information
About this company
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
Key people
Key facts
- EPICALBT
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- ISINUS05344R3021
- Market cap$5.25m
- Employees5
- Shares in issue1.10m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.